JYP-0061

The goal of this clinical trial is to evaluate the efficacy and safety of JYP0061 in adult patients with moderate-to-severe atopic dermatitis. The main questions it aims to answer are:
* The efficacy of JYP0061 in treating adult patients with moderate-to-severe atopic dermatitis.
* The safety profile of JYP0061 when administered to adult patients with moderate-to-severe atopic dermatitis.
Participants will:
* Be treated with either a low-dose or high-dose of JYP0061.
* Undergo efficacy and safety evaluations as stipulated in the trial protocol.